The results demonstrated that the 25mg daily pill delivered clinically meaningful weight loss: Average weight loss of 13.6-16.6% compared to 2.2-2.7% with placebo 76% of participants achieved at least 5% weight loss versus 31% on placebo Over 30% achieved 20% or greater weight loss Significant improvements in blood pressure, cholesterol, and inflammatory markers These results are comparable to what weve seen with injectable Wegovy, which typically produces 12-15% weight loss
Obesity is a lifelong disease and most patients will need ongoing treatment
By avoiding things like skipping water, drinking alcohol, overdoing exercise, and eating junk food, you give your body the best chance to benefit from the treatment
Flexible financing through Cherry is available, split into up to 26 monthly payments, which lets most patients start their protocol the same day as the consultation
Understanding survey methodology and limitations helps interpret results appropriately